Medical Oncology clinical trials

Explore recruiting medical oncology clinical trials.

Recruiting medical oncology studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Medical Oncology trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, open-label, non-comparative, single-arm, phase II trial of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with active brain metastases (The TUXEDO-5 Study)

Spain, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy of Olaparib in advanced cancers occurring in patients with germline mutations or somatic tumor mutations in homologous recombination genes.A Belgian Precision 2 study

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Medical Oncology trials by city

Medical Oncology in Toronto Medical Oncology in Vancouver Medical Oncology in Montreal Medical Oncology in Calgary Medical Oncology in Edmonton Medical Oncology in Ottawa Medical Oncology in Winnipeg Medical Oncology in Quebec City Medical Oncology in Hamilton Medical Oncology in Kitchener Medical Oncology in London Medical Oncology in Halifax Medical Oncology in New York Medical Oncology in Los Angeles Medical Oncology in Chicago Medical Oncology in Houston

Medical Oncology clinical trials

Recruiting medical oncology studies right now

A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial

A Phase II Study of Sacituzumab Tirumotecan in Combination With Furmonertinib in Patients With Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery

Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) Cancer

Implementation of a Tumor Response Assessment Program Integrating the Shared Medical Decision Into the Organ Preservation Strategy for Rectal Cancer Patients

Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments

Large Language Models to Aid Gynecological Oncology Treatment

Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients

Also recruiting in Europe

A multicenter, open-label, non-comparative, single-arm, phase II trial of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with active brain metastases (The TUXEDO-5 Study)

Efficacy of Olaparib in advanced cancers occurring in patients with germline mutations or somatic tumor mutations in homologous recombination genes.A Belgian Precision 2 study

Medical Oncology trials by city

Other conditions